Læknablaðið - 15.08.1995, Qupperneq 28

604
LÆKNABLAÐIÐ 1995; 81
12. Cherubin CE, Marr JS, Sierra MF, Becker S. Listeria
and gram-negative bacillary meningitis in New York
City, 1972-1979; frequent causes of meningitis in adults.
Am J Med 1981; 71: 199-209.
13. Steingrímsson Ó, Sigurðardóttir Ý, Jónsdóttir KE, Kris-
tinsson KG, Þorsteinsson SB. Listeríósis f mönnum á
íslandi á árunum 1978-1994. Læknablaðið 1995; 81: 589-
93.
14. Kaplan SL, Feigin RD. Clinical presentations, prognos-
tic factors and diagnosis of bacterial meningitis. In:
Sande MA, Smith AL, Root RK, eds. Contemporary
Issues in Infectious Diseases. Bacterial Meningitis. Vol.
3. New York: Churchill Livingstone, 1985: 83-95.
15. Wenger JD, Hightower AW, Facklam PR, Gaventa S,
Broome CV. Bacterial meningitis in the United States,
1986: report of a multistate surveiUance study. J Infect
Dis 1990; 162: 1316-23.
16. Edwards MS, Baker CJ. Streptococcus agalactiae
(group B streptococcus). In: Mandell GL, Douglas RG,
Dolin R, eds. Principals and Practice of Infectious Dis-
eases. 4th ed. New York: Churchill Livingstone, 1995:
1835^15
17. Kaplan SL, Woods CR. Neurologic complications of
bacterial meningitis in children. In: Remington JS,
Swartz MN, eds. Current Clinical Topics in Infectious
Diseases. Vol. 12. Boston: Blackwell Scientific Publi-
cations, 1992: 37-55.
18. Broome CV, Schlech IIIWF. Recent developements in
the epidemiology of bacterial meningitis. In: Sande MA,
Smith AL, Root RK, eds. Contemporary Issues in In-
fectious Diseases. Bacterial Meningitis. Vol. 3. New
York: Churchill Livingstone, 1985: 1-9.
19. HamiU RJ, Maki DG, Endotoxin shock in man caused
by gram-negative baciUi. In: Proctor RA, ed. Handbook
of Endotoxin. Vol 4: Clinical Aspects of Endotoxin
shock. Amsterdam: Elsevier Science Publishers B.V.,
1986: 55-126.
20. Tunkel AR,Wispelway B, Scheld WM. Bacterial menin-
gitis: recent advances in pathophysiology and treatment.
Ann Int Med 1990; 112: 610-23.
21. Guðmundsson S. Um notkun sýklalyfja II. Læknanem-
inn 1994; 47: 5-12.
22. Appelbaum PC. Antimicrobial resistance in Streptococ-
cus pneumoniae: an overview. Clin Inf Dis 1992; 15:
77-83.
23. Kristinsson KG, Hjálmarsdóttir MÁ, Steingrímsson Ó.
Increasing penicillin resistance in pneumococci in Ice-
land. Lancet 1992; 339: 1606-7.
24. Soares S, Kristinsson KG, Musser JM, Tomasz A. Evi-
dence for the introduction of a multiresistant clone of
serotype 6B Streptococcus pneumoniae from Spain to
Iceland in the late 1980s. J Infect Dis 1993; 168:158-63.
25. Jorgensen JH. Update on the mechanisms and preva-
lence of antimicrobial resistance in Hemophilus influen-
zae. Clin Inf Dis 1992; 14: 1119-23.
26. Glade MP. Post exposure prophylaxis for bacterial men-
ingitis. In: Sande MA, Smith AL, Root RK, eds. Con-
temporary Issues in Infectious Diseases. Bacterial Men-
ingitis. Vol. 3. New York: ChurchiU Livingstone, 1985:
123^41.
27. Hart CA, Rogers TRF. Meningococcal disease. J Med
Microbiol 1993; 39: 3-25.
28. Lebel MH, Freij BJ, Syrogiannopoulos GA. Dexameth-
asone therapy for bacterial meningitis. Results of two
double-blind, placebo-controlled trials. N Engl J Med
1988; 319: 964-71
29. Odio CM, Faingezicht I, Paris M, Nassar M, Baltodano
A, Rogers J, et al. The beneficial effects of early dexa-
methasone administration in infants and children with
bacterial meningitis. N Engl J Med 1991; 324: 1525-31.
30. Quagliarello V, Scheld WM. Bacterial meningitis: path-
ogenesis, pathophysiology, and progress. N Engl J Med
1992; 327: 864-72.
31. Bone RC, Fischer CJ, Clemmer TP, Slotman GJ, Metz
CA, Balk RA, et al. A controUed trial of high-dose
methylprednisolone in treatment of severe sepsis and
septic shock. N Engl J Med 1987; 317: 653-8.
32. Veterans Administration Systemic Sepsis Cooperative
Study Group. Effect of high dose glucocorticoid therapy
on mortality in patients with clinical signs of systemic
sepsis. N Engl J Med 1987; 317: 659-65.
33. Hodges GR, Perkins RL. Acute bacterial meningitis: an
analysis of factors influencing prognosis. Am J Med Sci
1975; 270: 427-40.